Smith Darren Charlton
Telix Pharmaceuticals Limited · Group Chief Financial Officer
Smith Darren Charlton is listed in filings as Group Chief Financial Officer at Telix Pharmaceuticals Limited. This profile follows SEC Form 4 activity through Apr 1, 2026, including 1 public disclosure. Recent filings connect the profile to Telix Pharmaceuticals Limited (TLX). The current snapshot covers public activity from Apr 1, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||